Differentiation and function of Foxp3+ effector regulatory T cells

Trends in Immunology

Volumn 34, Issue 2, 2013, Pages 74-80

  Cretney, Erika ^a,b   Kallies, Axel ^a,b   Nutt, Stephen L ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Autoimmune disease; B lymphocyte induced maturation protein 1; Differentiation; Interleukin 10; Regulatory T cell; Transcription

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GALECTIN 1; GAMMA INTERFERON; HISTONE H3; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 35; INTERLEUKIN 5; INTERLEUKIN 6; L SELECTIN; PADGEM PROTEIN; PROTEIN BCL 6; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; APOPTOSIS; AUTOIMMUNITY; CANCER PROGNOSIS; CELL EXPANSION; CELL LINEAGE; CELL SURVIVAL; CELLS; CELLULAR DISTRIBUTION; CHROMATIN STRUCTURE; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; GENE DELETION; GENE EXPRESSION PROFILING; GERMINAL CENTER; HERPES SIMPLEX; HISTONE MODIFICATION; HUMAN; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LISTERIOSIS; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SCLEROSIS; TISSUE INJURY; TUBERCULOSIS; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TYPHOID FEVER; WEST NILE FLAVIVIRUS;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; COMMUNICABLE DISEASES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; NEOPLASMS; REPRESSOR PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 84873160951     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.11.002     Document Type: Review

References (82)

1. Sakaguchi S., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995, 155:1151-1164.
2. Weiss J.M., et al. Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 2012, 209:1723-17423.
3. Josefowicz S.Z., et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012, 482:395-399.
4. Huehn J., et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 2004, 199:303-313.
5. Szanya V., et al. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 2002, 169:2461-2465.
6. Menning A., et al. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets. Eur. J. Immunol. 2007, 37:1575-1583.
7. Cretney E., et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 2011, 12:304-311.
8. Sakaguchi S., et al. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10:490-500.
9. Miyara M., et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
10. Ito T., et al. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 2008, 28:870-880.
11. Shevach E.M. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645.
12. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 2008, 9:239-244.
13. Vignali D.A., et al. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
14. Zhu J., et al. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 2010, 28:445-489.
15. Zheng Y., et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 458:351-356.
16. Chaudhry A., et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009, 326:986-991.
17. Koch M.A., et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 2009, 10:595-602.
18. Linterman M.A., et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 2011, 17:975-982.
19. Feuerer M., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009, 15:930-939.
20. Wohlfert E.A., et al. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J. Clin. Invest. 2011, 121:4503-4515.
21. Wang Y., et al. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 2011, 35:337-348.
22. Rudra D., et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat. Immunol. 2012, 13:1010-1019.
23. Chaudhry A., et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011, 34:566-578.
24. Duhen T., et al. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 2012, 119:4430-4440.
25. Crotty S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 2011, 29:621-663.
26. Yu D., Vinuesa C.G. The elusive identity of T follicular helper cells. Trends Immunol. 2010, 31:377-383.
27. Linterman M.A., et al. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 2009, 206:561-576.
28. Chung Y., et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 2011, 17:983-988.
29. Feuerer M., et al. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5919-5924.
30. Cipolletta D., et al. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012, 486:549-553.
31. Nishimura S., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
32. Winer S., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009, 15:921-929.
33. Moore K.W., et al. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
34. Rubtsov Y.P., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28:546-558.
35. Maynard C.L., et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 2007, 8:931-941.
36. Martins G., Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 2008, 26:133-169.
37. Nutt S.L., et al. BLIMP1 guides the fate of effector B and T cells. Nat. Rev. Immunol. 2007, 7:923-927.
38. Kallies A., et al. Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat. Immunol. 2006, 7:466-474.
39. Martins G.A., et al. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat. Immunol. 2006, 7:457-465.
40. Kallies A., et al. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity 2009, 31:283-295.
41. Rutishauser R.L., et al. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 2009, 31:296-308.
42. Cheng G., et al. IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J. Immunol. 2012, 189:1780-1791.
43. Sciammas R., et al. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 2006, 25:225-236.
44. Zhang R., et al. Regulation of T helper cell differentiation by interferon regulatory factor family members. Immunol. Res. 2012, 54:169-176.
45. Murai M., et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 2009, 10:1178-1184.
46. Kayama H., et al. Intestinal CX3C chemokine receptor 1 (high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5010-5015.
47. Seddiki N., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006, 203:1693-1700.
48. Baron U., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 2007, 37:2378-2389.
49. Zheng Y., Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 2007, 8:457-462.
50. Valencia X., et al. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006, 108:253-261.
51. Viglietta V., et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:971-979.
52. Sugiyama H., et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 2005, 174:164-173.
53. Lindley S., et al. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005, 54:92-99.
54. Balandina A., et al. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 2005, 105:735-741.
55. Ehrenstein M.R., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004, 200:277-285.
56. Nadkarni S., et al. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J. Exp. Med. 2007, 204:33-39.
57. Feng T., et al. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-gamma-producing Foxp3+ T cells that inhibit colitis. Gastroenterology 2011, 140:2031-2043.
58. Martinez-Llordella M., et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am. J. Transplant. 2007, 7:309-319.
59. Akl A., et al. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Transpl. Int. 2008, 21:65-73.
60. Meloni F., et al. Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 2004, 77:762-766.
61. Tao R., et al. Histone deacetylase inhibitors and transplantation. Curr. Opin. Immunol. 2007, 19:589-595.
62. Jiang S., Lechler R.I. Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am. J. Transplant. 2003, 3:516-524.
63. Lin C.Y., et al. Dominant transplantation tolerance impairs CD8+ T cell function but not expansion. Nat. Immunol. 2002, 3:1208-1213.
64. Cobbold S.P., et al. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 2004, 172:6003-6010.
65. Ochando J.C., et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J. Immunol. 2005, 174:6993-7005.
66. Zhang N., et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 2009, 30:458-469.
67. Rowe J.H., et al. Foxp3(+) regulatory T cells, immune stimulation and host defence against infection. Immunology 2012, 136:1-10.
68. Lanteri M.C., et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J. Clin. Invest. 2009, 119:3266-3277.
69. Lund J.M., et al. Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008, 320:1220-1224.
70. Oldenhove G., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
71. Haque A., et al. CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog. 2010, 6:e1001221.
72. Shafiani S., et al. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 2010, 207:1409-1420.
73. Johanns T.M., et al. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog. 2010, 6:e1001043.
74. Scott-Browne J.P., et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 2007, 204:2159-2169.
75. Rowe J.H., et al. Foxp3(+) regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 2011, 10:54-64.
76. Curiel T.J., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004, 10:942-949.
77. Hiraoka N., et al. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin. Cancer Res. 2006, 12:5423-5434.
78. Boissonnas A., et al. Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 2010, 32:266-278.
79. Tan W., et al. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature 2011, 470:548-553.
80. Strauss L., et al. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression. J. Immunol. 2008, 180:2967-2980.
81. Strauss L., et al. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 2007, 13:4345-4354.
82. Miller A.M., et al. CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J. Immunol. 2006, 177:7398-7405.